DK0494972T3 - Brusedosisform samt fremgangsmåde til administration heraf - Google Patents

Brusedosisform samt fremgangsmåde til administration heraf

Info

Publication number
DK0494972T3
DK0494972T3 DK90915661.4T DK90915661T DK0494972T3 DK 0494972 T3 DK0494972 T3 DK 0494972T3 DK 90915661 T DK90915661 T DK 90915661T DK 0494972 T3 DK0494972 T3 DK 0494972T3
Authority
DK
Denmark
Prior art keywords
shower
administration
dose form
present
swallow
Prior art date
Application number
DK90915661.4T
Other languages
Danish (da)
English (en)
Inventor
Navayanarao Madamala
Fred Wehling
Steve Schuehle
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Application granted granted Critical
Publication of DK0494972T3 publication Critical patent/DK0494972T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90915661.4T 1989-10-02 1990-09-13 Brusedosisform samt fremgangsmåde til administration heraf DK0494972T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41615289A 1989-10-02 1989-10-02
US50764290A 1990-04-11 1990-04-11
CA002061917A CA2061917C (en) 1989-10-02 1992-02-26 Pediatric effervescent dosage form

Publications (1)

Publication Number Publication Date
DK0494972T3 true DK0494972T3 (da) 1997-05-12

Family

ID=27169031

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90915661.4T DK0494972T3 (da) 1989-10-02 1990-09-13 Brusedosisform samt fremgangsmåde til administration heraf

Country Status (9)

Country Link
EP (2) EP0494972B1 (ja)
JP (2) JP3412694B2 (ja)
AT (1) ATE145551T1 (ja)
AU (1) AU646232B2 (ja)
CA (1) CA2061917C (ja)
DE (1) DE69029273T2 (ja)
DK (1) DK0494972T3 (ja)
ES (1) ES2097155T3 (ja)
WO (1) WO1991004757A1 (ja)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
DE4317646A1 (de) * 1993-05-27 1994-12-01 Asta Medica Ag Tabletten mit Thioctsäure und mindestens einer basischen Komponente
FR2715849B1 (fr) * 1994-02-09 1996-04-05 Xavier Hesnard Forme d'administration solide à délitescence rapide d'un principe actif.
JPH10501235A (ja) * 1994-06-03 1998-02-03 ザ、プロクター、エンド、ギャンブル、カンパニー 速溶解性剤形
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
CA2222176A1 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Compliance support package for increasing health management system compliance
CA2222278C (en) * 1995-06-06 2008-05-13 Campbell Soup Company Mineral supplements for dietetic food
WO1996039050A2 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Therapeutic system for dietary health management
US6039989A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Prepackaged therapeutic meal for treatment of diet-responsive conditions
US5560928A (en) * 1995-06-23 1996-10-01 Defelice; Stephen L. Nutritional and/or dietary composition and method of using the same
BR9611815A (pt) * 1995-07-31 1999-10-13 Gergely Gerhard Tablete de mascar com ação efervescente
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
DK0893992T3 (da) * 1996-04-16 2004-06-01 Novartis Consumer Health Sa Hurtigt sönderdelende oral doseringsform
IL129242A0 (en) * 1996-10-01 2000-02-17 Cima Labs Inc Taste-masked microcapsule compositions and methods of manufacture
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
DE19723042C2 (de) * 1997-06-02 1999-07-01 Rudy Thoma Iod enthaltende Süßstoffzubereitung
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
ATE323467T1 (de) * 1997-07-25 2006-05-15 Alpex Pharma Sa Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
FR2774291B1 (fr) 1998-02-03 2000-04-21 Innothera Lab Sa Specialite pharmaceutique sous forme galenique unitaire de comprimes a croquer ou a sucer, comprenant comme principe actif du fer element
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6576250B1 (en) 1998-03-27 2003-06-10 Cima Labs Inc. Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
DE19814392A1 (de) * 1998-03-31 1999-10-07 Hermes Fabrik Pharm Praeparate Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff
FR2787715B1 (fr) * 1998-12-23 2002-05-10 Synthelabo Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
US6680071B1 (en) 1999-03-03 2004-01-20 R. P. Scherer Technologies, Inc. Opioid agonist in a fast dispersing dosage form
AU2004242477B2 (en) * 1999-03-26 2007-04-19 Cima Labs Inc. Sublingual buccal effervescent
AU2007203233B2 (en) * 1999-03-26 2010-02-25 Cima Labs Inc. Sublingual buccal effervescent
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
PT1212045T (pt) 1999-08-24 2016-11-22 Abic Biological Laboratories Ltd Composição de vacina e método de utilização da mesma
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
TWI256309B (en) * 1999-10-13 2006-06-11 Akzo Nobel Nv New formulation of mirtazapine
KR100759720B1 (ko) 2000-06-30 2007-10-04 아스텔라스세이야쿠 가부시키가이샤 구강내 속붕괴정
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
JP2005519865A (ja) * 2001-09-25 2005-07-07 ランバクシー ラボラトリーズ リミテッド 急速溶解性投薬形態物の製造方法
JP4995407B2 (ja) 2002-04-25 2012-08-08 バナー ファーマキャップス， インコーポレーテッド 咀嚼可能なソフトカプセル
FI20022007A0 (fi) 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
DE60313216T2 (de) 2002-12-20 2008-01-03 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
DE602005003343T2 (de) 2004-04-12 2008-09-11 Pfizer Products Inc., Groton Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
US20080279935A1 (en) * 2005-02-18 2008-11-13 Swg Invest As Composition Comprising a Powder Containing Microencapsulated Polyunsaturated Long-Chain Esterified Fatty Acids Distributed in an Effervescent Base
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
CN101460150B (zh) 2006-03-31 2014-02-12 鲁比康研究私人有限公司 用于口腔崩解片剂的可直接压片复合物
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
WO2008065504A1 (en) 2006-11-30 2008-06-05 Pfizer Products Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
CA2617688C (en) * 2007-02-22 2015-08-18 Alpex Pharma S.A. Solid dosage formulations containing weight-loss drugs
DE102007041588A1 (de) 2007-09-01 2009-03-05 Lts Lohmann Therapie-Systeme Ag Arzneimittel mit Hefe
JP2009137872A (ja) * 2007-12-05 2009-06-25 Lion Corp グルクロノラクトン含有経口用固形製剤
EP2384742A1 (en) 2010-05-03 2011-11-09 The Jordanian Pharmaceutical Manufacturing Co. Pharmaceutical excipient, method for its preparation and use thereof
JP5560104B2 (ja) * 2010-06-07 2014-07-23 ライオン株式会社 アスコルビン酸（塩）含有固形製剤
JP5697668B2 (ja) 2010-07-09 2015-04-08 帝人ファーマ株式会社 口腔内崩壊錠剤
SG11201705092TA (en) * 2015-01-14 2017-07-28 Pfizer Oral delivery product
WO2018117855A1 (en) * 2016-12-20 2018-06-28 X-Ing As Effervescent lozenge
US11529492B2 (en) 2017-06-28 2022-12-20 Mayo Foundation For Medical Education And Research Methods and materials for treating hypocapnia
CN109303334B (zh) * 2018-10-17 2021-04-13 汤臣倍健股份有限公司 一种口腔微泡腾片及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB189403160A (ja) *
US1262888A (en) 1917-02-20 1918-04-16 Albert Westlake Mouth-tablet.
US2887437A (en) 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US3042531A (en) 1959-12-09 1962-07-03 Leslie Salt Company Method of making a compressed tablet
SE369036B (ja) * 1972-06-30 1974-08-05 Astra Laekemedel Ab
US3962417A (en) 1974-03-27 1976-06-08 Howell Charles J Dentifrice
US4613497A (en) 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
GB8421226D0 (en) 1984-08-21 1984-09-26 Int Conferences Ab Tooth cleaning tablet
US4639368A (en) 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4687662A (en) 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
GB8525348D0 (en) * 1985-10-15 1985-11-20 Nicholas Kiwi Pacific Pty Ltd Effervescent tablets
IE873172L (en) 1986-12-29 1988-06-29 Harvard College Continuous process for producing a comestible tablet
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
GB8909793D0 (en) 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
CA2061917A1 (en) 1993-08-27
DE69029273T2 (de) 1997-06-12
AU646232B2 (en) 1994-02-17
EP0494972A1 (en) 1992-07-22
JP3412694B2 (ja) 2003-06-03
EP0494972B1 (en) 1996-11-27
ATE145551T1 (de) 1996-12-15
ES2097155T3 (es) 1997-04-01
DE69029273D1 (de) 1997-01-09
EP0494972A4 (en) 1992-08-12
AU6601290A (en) 1991-04-28
EP0737473A1 (en) 1996-10-16
JPH05500956A (ja) 1993-02-25
JP2003231629A (ja) 2003-08-19
CA2061917C (en) 1999-02-02
WO1991004757A1 (en) 1991-04-18

Similar Documents

Publication Publication Date Title
DK0494972T3 (da) Brusedosisform samt fremgangsmåde til administration heraf
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
WO1994027589A3 (en) Antidepressant dosage form
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
ZA926241B (en) Dosage form for delivering drug in short-time period
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
DE3783430D1 (de) Bedingte dosierungsvorrichtung.
DE3852877T2 (de) Pharmazeutische Zubereitungen zur Verhütung von Arzneimitteltoleranz.
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
DE69203990D1 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
HK1003980A1 (en) Dosage form for dispensing drug and human therapy
NZ225242A (en) Pad printing process for manufacturing a pharmaceutical presentation and/or dosage form for active ingredients of drugs
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
DE68912341T2 (de) Pharmazeutische zusammensetzungen mit gehalt an calcitonin zur intranasalen verabreichung und eine spray-einheit zur verabreichung derselben.
NO892764L (no) Medikamentell administreringsform for droevtyggere.
IT8722031A0 (it) Formulazioni farmaceutiche e forme di dosaggio per la somministrazione rettale di calcitonina.
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
DK39584A (da) Anvendelse af nafazatrom til forebyggelse og behandling af diverse sygdomme, laegemidler indeholdende nafazatrom samt fremgangsmaader til disses fremstilling
NO873805L (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.
ATE99951T1 (de) Pharmazeutische zusammensetzungen mit gehalt an calcitonin zur intranasalen verabreichung und eine spray-einheit zur verabreichung derselben.
TH19526A (th) วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.